Mark R. Hake

CFA

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks .

Recent Articles

Nio Stock: Cash Injection Provides Liquidity Needed To Survive

By Mark R. Hake, CFA Jul 2, 2020

Nio's cash injection provides the cash needed to survive. Nio's new strategic partnership provides $1 billion are a lifeline for Nio stock.

To Invest in Tesla Stock Take the Long-Term View

By Mark R. Hake, CFA Jul 1, 2020

To invest in Tesla stock take the long term view. The stock's long-term valuation and prospects depend on its performance 10 years from now.

There’s Hope for Profitability By Next Spring For Delta

By Mark R. Hake, CFA Jun 30, 2020

Delta's plan to get profitable by spring brings hope to DAL stock. If it hits breakeven, investors today can expect to make 67% on DAL stock.

Why Exxon’s Dividend Is Safe and Attractive

By Mark R. Hake, CFA Jun 30, 2020

Exxon's dividend is safe, making the XOM stock 7.7% yield very attractive. The expected total return for XOM stock, including the dividend, is over 30% annually over the next two years.

Increasing Oil Prices Alone Can’t Save Marathon Oil

By Mark R. Hake, CFA Jun 30, 2020

Marathon Oil might not recover until its oil hedges are profitable. And without that, the MRO stock outlook isn't all that positive.